Price
20.83
-4.63%52W Range
Market Cap
₹308.15 Cr
Traded: ₹1.09 Cr (0.35%) 0.0x
Free Float: ₹257.89 Cr (0.42% of FF traded)
Volume · 60D trend
5.16 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -10.0% | -104.0% | -47.0% | -- | -- | Stable |
| Sales | -26.0% | -41.0% | -34.0% | -- | -- | Stable |
| Profit | -27.0% | +15.0% | +27.0% | -- | -89.0% | Stable |
| Return | -15.0% | -16.0% | +17.0% | +180.0% | -- | Accelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 30 | 54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 38 | 51 | 43 |
| Expenses | 31 | 55 | 0 | 0 | 0 | 1 | 3 | 1 | 2 | 16 | 2 | 2 | 6 | 27 | 55 | 70 |
| Operating Profit | -0 | -1 | -0 | -0 | -0 | -1 | -3 | -1 | -2 | -16 | -2 | -1 | -2 | 11 | -4 | -26 |
| OPM % | -0.9% | -1.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2900.0% | -54.9% | 29.3% | -8.2% | -61.0% |
| Other Income | 1 | 5 | 1 | 7 | -0 | -3 | 51 | -0 | -1 | -94 | 4 | 0 | -2 | -59 | 1 | 23 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 4 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | 4 |
| Profit Before Tax | 1 | 4 | 1 | 6 | -1 | -5 | 48 | -2 | -4 | -110 | 1 | -2 | -5 | -56 | -8 | -8 |
| Tax % | 0.0% | 0.0% | 0.0% | 2.5% | 0.0% | 0.0% | 0.0% | -3.7% | 1.6% | 0.6% | 248.6% | -18.4% | 3.5% | -0.2% | 30.8% | -0.4% |
| Net Profit | 1 | 4 | 1 | 6 | -1 | -5 | 48 | -2 | -4 | -111 | -2 | -2 | -5 | -56 | -10 | -8 |
| Exceptional Items | 0 | 0 | 0 | 7 | -0 | -5 | 43 | -0 | -1 | -94 | 3 | 0 | -2 | -57 | 0 | 19 |
| EPS (Rs) | 0.1 | 0.3 | 0.1 | 0.4 | -0.1 | -0.3 | 3.2 | -0.1 | -0.3 | -7.5 | -0.1 | -0.1 | -0.4 | -3.8 | -0.7 | -0.5 |
| Sales Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | -99.9% | -93.8% | -8.3% | -- | -- |
| Sales Growth (QoQ) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -100.0% | -98.6% | -90.5% | -26.0% | 17.0% | -- |
| OP Growth (YoY) | 38.6% | 28.7% | 87.9% | 66.7% | 80.2% | 92.7% | -46.0% | 37.9% | -13.8% | -243.3% | 52.2% | 94.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 67.1% | -134.3% | -16.7% | 31.8% | 61.7% | 60.2% | -221.1% | 59.5% | 85.9% | -696.0% | -36.6% | 25.6% | -117.7% | 365.7% | 84.3% | -- |
| Profit Growth (YoY) | 283.0% | 1353.0% | -77.0% | 53.0% | 79.0% | 102.0% | 190.0% | 27.0% | 10.0% | -963.0% | 48.0% | 93.0% | 22.0% | 95.0% | 75.0% | -202.0% |
| EPS Growth (YoY) | -- | 187.9% | -97.5% | 490.9% | 76.0% | 95.6% | 2400.0% | -10.0% | 30.6% | -97.9% | 79.7% | 81.5% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 262.5% | -81.4% | 816.7% | 81.8% | -110.3% | 3027.3% | 56.0% | 96.7% | -5242.9% | -40.0% | 72.2% | 90.5% | -447.8% | -27.8% | -- |
| OP Margin | -- | -1.5% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2900.0% | -54.9% | 29.3% | -8.2% | -61.0% |
| Net Margin | -- | 8.1% | -- | -- | -- | -- | -- | -- | -- | -- | -- | -3100.0% | -149.9% | -149.1% | -19.4% | -18.9% |
| Material Cost % | 100.0% | 100.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0% | 89.0% | 54.0% | 40.1% | 47.9% |
| Employee Cost % | 0.0% | 0.0% | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1060.0% | 18.0% | 8.0% | 11.1% | 32.1% |
| P/S | 3.63 | 6.35 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 23.94 | 31.42 | 223.33 | 12.95 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 9.94 | 11.10 | 15.47 | 24.02 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Submission of Voting Results of Postal Ballot along with Scrutinizer''s Report.
Newspaper Advertisement of the Unaudited Financial Results for the quarter ended June 30, 2026.
Press Release on Financial Results of the Company for the quarter ended June 30, 2026.
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.
Take Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....
Submission of Newspaper Publication of Notice of Postal Ballot.
Certificate pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30, 2026.
Intimation of Notice of Postal Ballot.
Outcome of the Board Meeting for declaration of Postal Ballot.
Receipt of Certificate of Incorporation consequent upon change of name of the Company from TAKE SOLUTIONS LIMITED to TAKE LIMITED.
Closure of Trading Window for the quarter ending June 30, 2026.
This resubmission is made to comply with prescribed format of Statement on Impact of Audit Qualifications, duly signed by all requisite signatories under Regulation 33 of the SEBI (Listing ....
Submission of Voting Results of Postal Ballot along with Scrutinizer''s Report.
Annual Secretarial Compliance report of the Company for the financial year ended March 31, 2026.
Resignation and Appointment of Secretarial Auditor of the Company.
Newspaper Advertisement of the Audited Financial Results for the quarter and financial year ended March 31, 2026
Press Release - Audited Financial Results for the quarter and financial year ended 31 March 2026.
The meeting of the Board of Directors of the company was held today i.e. Wednesday, May 20, 2026 at the Registered office of the company. The board has considered and approved the Audited ....
Standalone and Consolidated Financial Results as on 31 March 2026.
The Board of Directors of the Company at its meeting held today, i.e. Tuesday, May 19, 2026, have inter alia considered and approved the Appointment of Mr. Sunil Patra (DIN: 11728362) as ....
Newspaper Clipping for the dispatch of Postal Ballot Notice dated 13th May 2026.
Take Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated ....
Notice of Postal Ballot dated May 13, 2026
Please find enclosed herewith the Outcome of the Board Meeting held on Wednesday, May 13, 2026, inter alia approving change in name of the Company, alteration and adoption of Memorandum ....
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Take Solutions Announces plans to disrupt the Indian Longevity and Anti-ageing Solutions.
Certificate pursuant to Regulation 74 (5) of SEBI (Depositories and Participants) Regulation 2018.
TAKE Solutions Launches Rs. 50 Million Innovation Fund to back AI, Deep Tech and Digital Health Startups.
Appointment of M/s. A. Raghavendra Rao & Associates, Chartered Accountants as the Statutory Auditors of the Company.
Appointment of M/s. A. Raghavendra Rao & Associates, Chartered Accountants, (FRN: 003324S and PRC No.: 018363) as the Statutory Auditors of the Company to fill the casual vacancy.
Intimation regarding resignation of Statutory Auditor of the Company.
Closure of Trading Window for the quarter and year ending on March 31, 2026
Press Release - TAKE Solutions Launches Take.Health - An Intelligent Health Companion Targeting India''s $197 Billion Healthcare Opportunity.
We would like to inform you that the Company has formed a wholly owned subsidiary under the name and style of "TAKE VENTURES PRIVATE LIMITED".
Voting Results of Extra Ordinary General Meeting along with Scrutinizer''s report.
Submission of Proceedings of the Extra Ordinary General Meeting of the Company.
Take Solutions Accelerate AI Dominance in $370B Healthcare sector, the Press Release on the same is enclosed herewith for your reference and record.
Cut-off Date for determining Members Eligible for e-voting for the purpose of the Extra Ordinary General Meeting is 28th February 2026.
Press Release - TAKE Solutions to build a Scalable Unified AI Platform, aligning with the IndiaAI Mission.
Newspaper Advertisement of the Unaudited Financial Results for the quarter and nine months ended December 31, 2025.
The Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2025, along with the Limited Review Report thereon
Results for the quarter and nine months ended 31 December 2025 along with Limited Review Report.
Newspaper Advertisement of Notice of Extra Ordinary General Meeting
Extra Ordinary General Meeting of the members of the Company is scheduled to be held on Saturday, March 07, 2026 at 12 noon through virtual mode.
Kindly refer Outcome of Board Meeting for further details.
Amendment to MOA regarding shifting of registered office from the state of Tamil Nadu to the state of Maharashtra, subject to necessary approvals.
Appointment of Mr. Vilas Munis (DIN: 11533598) as Additional Non-Executive Non-Independent Director of the Company.
For Further details kindly refer to the enclosed outcome.
Take Solutions Announces Plans to set up "One Minute Clinic" in India with the vision to make early health screening more accessible, intelligent and affordable.
Annual Reports
15Credit Ratings
6Concalls
22Aug 2021
31 Aug 2021Jun 2021
30 Jun 2021Feb 2021
28 Feb 2021Dec 2020
31 Dec 2020Sep 2020
30 Sept 2020Oct 2019
31 Oct 2019Aug 2019
31 Aug 2019May 2019
31 May 2019Mar 2019
31 Mar 2019Feb 2019
28 Feb 2019Feb 2019
28 Feb 2019Aug 2018
31 Aug 2018May 2018
31 May 2018Feb 2018
28 Feb 2018Nov 2017
30 Nov 2017Nov 2017
30 Nov 2017Aug 2017
31 Aug 2017May 2017
31 May 2017Jan 2017
31 Jan 2017Dec 2016
31 Dec 2016Oct 2016
31 Oct 2016Feb 2016
29 Feb 2016